Clinical and immunomodulatory effects of bevacizumab and low-dose interleukin-2 in patients with metastatic renal cell carcinoma: results from a phase II trial Article

cited authors

  • Garcia, Jorge A.; Mekhail, Tarek; Elson, Paul; Triozzi, Pierre; Nemec, Cheryl; Dreicer, Robert; Bukowski, Ronald M.; Rini, Brian I.

authors

Publication Date

  • February 1, 2011

webpage

published in

category

keywords

  • bevacizumab
  • immunomodulatory
  • low-dose interleukin-2
  • phase II

start page

  • 562

end page

  • 570

volume

  • 107

issue

  • 4